Extendicare (TSE:EXE – Free Report) had its price objective upped by Canadian Imperial Bank of Commerce from C$22.00 to C$32.00 in a research note published on Thursday morning,BayStreet.CA reports.
Several other analysts have also weighed in on the company. BMO Capital Markets upped their price objective on Extendicare from C$24.00 to C$30.00 in a report on Monday, March 2nd. Royal Bank Of Canada raised Extendicare from a “hold” rating to a “moderate buy” rating and lifted their target price for the stock from C$15.00 to C$25.00 in a report on Thursday, December 4th. Cormark boosted their price target on shares of Extendicare from C$25.00 to C$30.00 in a research report on Wednesday, December 3rd. Canaccord Genuity Group upped their price target on shares of Extendicare from C$20.00 to C$22.50 in a report on Thursday, December 4th. Finally, National Bank Financial raised their price objective on shares of Extendicare from C$24.50 to C$29.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of C$26.79.
Get Our Latest Stock Report on EXE
Extendicare Stock Performance
Extendicare (TSE:EXE – Get Free Report) last issued its quarterly earnings results on Thursday, February 26th. The company reported C$0.29 earnings per share (EPS) for the quarter. Extendicare had a return on equity of 47.65% and a net margin of 5.82%.The firm had revenue of C$462.03 million during the quarter. Research analysts predict that Extendicare will post 0.6134729 EPS for the current fiscal year.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
